Scilex Holding Company
SCLXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for SCLX. That does not mean none is planned.
Get an email about SCLX's next catalysts
Track Scilex Holding Company (SCLX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
SCLX Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
Frequently asked questions
What is in Scilex Holding Company's drug pipeline?→
CatalystAlert tracks 2 drug candidates in Scilex Holding Company's (SCLX) pipeline across Phase 3, Phase 2. Its lead program is SP-102 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Scilex Holding Company's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Scilex Holding Company (SCLX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SCLX biotech catalysts?→
Add SCLX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Scilex Holding Company's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.